Characteristics and Outcomes of Gastrointestinal Manifestations of COVID-19

Infectious Clinical Trial

Official title:

Characteristics and Outcomes of Gastrointestinal Manifestations of COVID-19

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04490772
• Other study ID #: COVID gastro intestinal
• Status: Not yet recruiting
• Start date: July 2020
• Est. completion date: September 2020

Study information

• Verified date: July 2020
• Source: Assiut University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Patients confirmed COVID-19 with gastrointestinal manifestations will be included. Characteristics and outcomes will be described for them.

Description:

Patients diagnosed as confirmed Covid-19 according to WHO and Egyptian Ministry of Health and Population (MOH) definitions will be included.The following will be done for all patients:

Demographic characters; age, sex, presence of co-morbidities such as hypretension, diabetes mellitus, obstructive lung diseases, ischemic heart diseases...etc, history of contact to covid-19 patients or recent travelling abroad.Clinical Characteristics: By recording of clinical manifestation such as fever, cough, shortness of breath, sore throat, change in taste or smell, nausea,vomiting and diarrhea will be done. Complications and the type of treatment received by the patients will also be described including mechanical ventilation.

Laboratory data will also be included : blood picture, liver enzymes, ESR,CRP, serum ferritin, D-dimer and troponin.

Follow up of the patients will be done until improvement, deaths or complications to determine disease outcomes.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 200
• Est. completion date: September 2020
• Est. primary completion date: September 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Confirmed Covid-19 with GIT manifestations

Exclusion Criteria:

• Patients refuse to participate

Related Conditions & MeSH terms

• Communicable Diseases
• Infection
• Infectious

Intervention

Diagnostic Test:
• Laboratory tests
Laboratory tests such as CBC, Liver function and CRP

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Clinical data questionnaire	Clinical characteristics of age, sex, comorbidities and symptoms.	2 months
Primary	Tests such as CBC	Laboratory characters	2 months
Primary	liver function test	Laboratory characters	2 months